Postoperative Inflammation
📧 Sign up to get email alerts when something new happens for Postoperative Inflammation.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-02-10Clinical Trial Update: Dextenza in the Post-op Management of Vitreoretinal Surgeries [Phase 4]
Phase 4 clinical trial update evaluating Dextenza for post-operative management of vitreoretinal surgeries, focusing on ocular inflammation …
-
FDA approval · 2026-01-26FDA Approved: DIFLUPREDNATE — Original Application (Alembic Pharmaceuticals Inc.)
FDA approved Alembic Pharmaceuticals' difluprednate ophthalmic emulsion 0.05% as a generic version for treating inflammation of the eye and …
-
FDA approval · 2025-02-11FDA Approved: DIFLUPREDNATE — Original Application (Upsher-Smith Laboratories, LLC)
FDA approved the original application for difluprednate from Upsher-Smith Laboratories, enabling a generic ophthalmic corticosteroid for pos…
-
FDA approval · 2025-01-28FDA Approved: LOTEPREDNOL ETABONATE — Supplemental Application (ARMAS PHARMACEUTICALS INC.)
FDA approves a supplemental application for Loteprednol Etabonate from Armas Pharmaceuticals Inc. under ANDA 212080, finalizing the status o…
-
CLINICAL_TRIALS research · 2024-07-12Clinical Trial Update: Efficacy of NSAID vs. Steroid-NSAID Combo Post-Selective Laser Trabeculoplasty: Phase 4, Single-Center RCT [Phase 4]
Phase 4 trial comparing NSAID alone versus a steroid-NSAID combination to manage postoperative inflammation after selective laser trabeculop…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2020-09-16Clinical Trial Update: The PRIME Study: A Randomized, Controlled, Prospective Study [Phase 4]
A Phase 4 randomized controlled prospective study titled 'The PRIME Study' is currently recruiting, focusing on patient preference and outco…
-
CLINICAL_TRIALS research · 2016-11-30Clinical Trial Update: OPEN-LABEL, MULTI-CENTER, PHASE 1b/2a CLINICAL TRIAL DESIGNED TO EVALUATE THE SAFETY AND EFFICACY OF IONTOPHORETIC DEXAMETHASONE PHOSPHATE OPHTHALMIC SOLUTION IN PATIENTS HAVING UNDERGONE CATARACT SURGERY WITH IMPLANTATION OF A POSTERIOR CHAMBER INTRAOCULAR LENS (IOL) [Phase 1, Phase 2]
Open-label, multi-center Phase 1b/2a trial to evaluate the safety and efficacy of iontophoretic dexamethasone phosphate ophthalmic solution …
-
CLINICAL_TRIALS research · 2015-07-24Clinical Trial Update: Comparison of Diclofenac vs. Nepafenac Ophthalmic Drops: Patient Comfort [NA]
This clinical trial compares diclofenac and nepafenac ophthalmic drops to evaluate patient comfort in post-surgical eye pain and inflammatio…
-
FDA approval · 2012-10-16FDA Approved: ILEVRO — Original Application (Novartis Pharmaceuticals Corporation)
FDA approved ILEVRO (nepafenac) from Novartis Pharmaceuticals Corporation as the original application for reducing postoperative pain and in…
-
CLINICAL_TRIALS trial_result · 2012-01-13Clinical Trial Update: Evaluation of Loteprednol Etabonate Versus Vehicle for the Treatment of Inflammation and Pain Following Cataract Surgery [Phase 3]
A Phase 3 trial compares Loteprednol Etabonate with vehicle for treating inflammation and pain after cataract surgery, with results posted i…
-
CLINICAL_TRIALS trial_result · 2011-06-30Clinical Trial Update: Study of Difluprednate in the Treatment of Inflammation Following Ocular Surgery (ST-601-003) [Phase 3]
A Phase 3 study evaluating difluprednate for treating ocular inflammation after surgery has completed.
-
CLINICAL_TRIALS trial_result · 2009-10-01Clinical Trial Update: A Study of Ketorolac for the Treatment of Inflammation and Pain Associated With Cataract Surgery [Phase 3]
Phase 3 trial evaluating ketorolac for reducing inflammation and pain after cataract surgery; results were posted in 2009.
-
CLINICAL_TRIALS trial_result · 2009-08-07Clinical Trial Update: Efficacy/Safety of Antibiotic Steroid Combination in Prevention of Post Operative Inflammation in LASIK Surgery [NA]
A completed clinical trial evaluated the efficacy and safety of an antibiotic-steroid combination to prevent postoperative inflammation foll…
-
FDA approval · 2008-05-08FDA Approved: NEVANAC — Supplemental Application (Harrow Eye, LLC)
FDA approved a supplemental application for NEVANAC (nepafenac) from Harrow Eye, LLC.
-
CLINICAL_TRIALS trial_result · 2006-12-06Clinical Trial Update: Study of Difluprednate Ophthalmic Emulsion in the Treatment of Postoperative Inflammation [Phase 2]
This update notes the completion of a Phase 2 study evaluating difluprednate ophthalmic emulsion for postoperative inflammation.
-
CLINICAL_TRIALS trial_result · 2006-12-04Clinical Trial Update: Study of Difluprednate Ophthalmic Emulsion in the Treatment of Postoperative Inflammation [Phase 2]
Completed Phase 2 clinical trial evaluating difluprednate ophthalmic emulsion for postoperative inflammation.